Salvage therapy for primary central nervous system lymphoma with ⁹⁰Y-Ibritumomab and Temozolomide

Author： Pitini Vincenzo Baldari Sergio Altavilla Giuseppe Arrigo Carmela Naro Claudia Perniciaro Francesca

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.83, Iss.3, 2007-07, pp. : 291-293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma

By Zhang Jun-Ping Lee Eudocia Nayak Lakshmi Doherty Lisa Kesari Santosh Muzikansky Alona Norden Andrew Chen Huichao Wen Patrick Drappatz Jan

Journal of Neuro-Oncology, Vol. 115, Iss. 1, 2013-10 ,pp. : 71-77

Springer Publishing Company

Access to resources Recommend Favorite

Combined Therapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By Ferreri A.J.M. Reni M. Bolognesi A. Verusio C. Villa E.

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2008-2012

Elsevier

Access to resources Recommend Favorite

Angiogenesis in primary central nervous system lymphoma (PCNSL)

By Takeuchi Hiroaki Matsuda Ken Kitai Ryuhei Sato Kazufumi Kubota Toshihiko

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 141-145

Springer Publishing Company

Access to resources Recommend Favorite

Diagnostic delay in primary central nervous system lymphoma

By Haldorsen Ingfrid S. Espeland Ansgar Larsen John Ludvig Mella Olav

Acta Oncologica, Vol. 44, Iss. 7, 2005-10 ,pp. : 728-734

Informa Healthcare

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma: Treatment with Chemotherapy and Radiotherapy

By Sarazin M. Ameri A. Monjour A. Nibio A. Poisson M. Delattre J.Y.

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2003-2007

Elsevier

Access to resources Recommend Favorite